BOSTON SCIENTIFIC CORPORATION BSX Cash Flow

Boston scientific corporation (BSX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Increase (decrease) in operating assets and liabilities, net of acquisitions:
Cash provided by (used for) operating activities
1,409	1,836	1,163	1,162	467	310	975	926	1,626	1,426	1,418	935	1,059	1,182	926	1,365	1,004	691	711	649	874	1,269	1,104	1,009	1,121	1,110	1,224	1,245	1,255	1,280	1,240	1,334	1,317	1,008	1,108	616	512	325	-453	157	290	835	0	0	0
Investing activities:
Purchases of property, plant and equipment
498	461	381	336	319	316	289	273	267	319	407	418	428	376	294	293	261	247	241	227	246	259	264	265	251	245	223	212	213	226	247	270	301	304	284	293	271	272	296	309	322	312	0	0	0
Proceeds from sale of property, plant and equipment
8	7	19	16	16	14	0	0	0	-	-	-	-	29	29	29	30	0	0	0	0	-	-	-	-	53	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of privately-held securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of publicly traded and privately held equity securities and collections of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for acquisitions of businesses, net of cash acquired
4,061	4,382	4,862	1,793	1,760	1,448	1,136	586	569	560	0	0	0	-	-	-	-	-	-	-	-	486	761	346	282	274	0	0	0	-	-	-	-	370	0	0	0	-	-	-	-	4	0	0	0
Proceeds from divestiture of certain businesses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	12	12	42	30	0	0	0	-	-	-	-	1,440	0	0	0	-	-	-	-	-	-	-	-
Proceeds from Collection of Notes Receivable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-91	0	0	0
Payments for investments and acquisitions of certain technologies
123	149	161	175	97	172	190	196	206	131	116	138	142	132	369	305	282	266	27	27	17	26	32	38	48	44	17	28	29	22	19	2	2	11	11	12	11	6	0	0	0	-	-	-	-
Proceeds from sales of investments and collections of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Cash provided by (used for) investing activities
-4,707	-5,041	-5,587	-2,287	-2,158	-1,921	-1,615	-1,055	-1,043	-1,010	-1,253	-1,356	-979	-887	-525	-2,039	-2,183	-2,186	-2,099	-853	-731	-745	-1,025	-625	-529	-475	-385	-365	-524	-579	-357	-363	-258	776	576	556	574	-468	-277	-291	-350	-793	0	0	0
Financing activities:
Payment of contingent consideration and royalty rights previously established in purchase accounting
204	135	138	78	26	19	19	20	15	33	60	48	62	65	89	104	90	156	121	106	109	34	68	160	172	160	249	157	143	146	11	11	10	7	0	0	0	-	-	-	-	523	0	0	0
Payments on short-term borrowings
300	1,000	1,000	1,000	1,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from short-term borrowings, net of debt issuance costs
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in commercial paper
-1,659	-575	437	224	707	21	-473	642	867	1,183	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on borrowings from credit facilities
479	0	0	0	0	-	-	-	-	2,216	2,456	2,746	1,265	570	330	210	605	565	565	555	525	810	910	750	385	340	360	360	500	380	400	575	435	565	425	250	250	200	0	0	0	-	-	-	-
Proceeds from borrowings on credit facilities
1,839	0	0	0	499	569	569	569	1,210	2,156	2,456	2,746	1,606	630	330	210	605	565	565	555	525	810	910	750	385	340	360	360	491	371	391	566	435	565	425	250	250	200	0	0	0	-	-	-	-
Payments on long-term borrowings and debt extinguishment costs
3,088	3,560	1,472	1,472	1,472	602	602	1,002	1,352	1,000	1,000	600	500	250	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,250	1,850	1,850	2,000	1,500	3,000	3,225	2,325	2,825	0	0	0
Proceeds from long-term borrowings, net of debt issuance costs
2,986	7,229	6,241	4,241	4,240	987	989	989	990	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for acquisitions of treasury stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	125	350	425	525	500	375	550	562	600	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash used to net share settle employee equity awards
62	65	66	65	66	56	55	55	54	65	69	68	66	62	61	60	62	66	65	66	65	51	-6	-6	-5	-28	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuances of shares of common stock
112	123	120	111	116	101	100	94	90	85	82	82	117	111	125	117	87	114	105	97	90	60	67	88	88	74	60	31	22	21	19	21	21	21	25	26	26	31	29	34	35	33	0	0	0
Cash provided by (used for) financing activities
1,102	2,973	4,122	2,959	3,429	1,432	939	649	255	110	206	379	-170	-206	-471	256	1,319	1,276	1,499	756	-84	-150	-401	-557	-670	-624	-621	-722	-746	-764	-810	-750	-1,369	-1,728	-2,029	-1,836	-1,013	-508	-26	-246	-318	-820	0	0	0
Effect of foreign exchange rates on cash
1	10	-1	-3	-9	-8	-8	-3	4	4	0	0	-3	-2	2	-2	1	-4	-7	-6	-8	-4	-3	0	1	-1	1	1	-1	3	3	-4	-1	-2	-3	7	3	0	0	0	0	-	-	-	-
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
-2,196	-222	-304	1,829	1,728	-188	291	518	842	530	371	-43	-93	87	-68	-420	141	-223	104	546	51	370	-325	-173	-77	10	219	159	-16	-60	76	217	-311	54	-348	-657	76	-651	-757	-383	-378	-777	0	0	0
Adjustments to reconcile net income (loss) to cash provided by operating activities
Stock-based compensation expense
163	157	152	146	140	140	135	133	133	127	125	120	118	116	115	112	109	107	103	103	103	103	107	108	107	105	100	101	105	108	117	120	123	128	124	123	126	150	155	158	155	144	0	0	0
Fair value of contingent consideration recorded in purchase accounting
40	127	185	239	335	248	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	3	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-